AN2 Therapeutics, Inc.
NASDAQ:ANTX
1.255 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -12.747 | -14.435 | -16.617 | -16.898 | -16.707 | -15.804 | -15.323 | -11.842 | -11.339 | -10.12 | -7.655 | -7.545 | -6.943 | -5.007 | -2.048 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0.414 | 0 | 0.021 | -0.435 | -0.692 | 0.02 | 0.019 | 0.001 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0.021 | 0 | -0.021 | 0 | 0 | -0.02 | -0.019 | -0.001 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 1.902 | 2.271 | 2.385 | 2.232 | 2.169 | 1.943 | 2.068 | 1.472 | 1.228 | 1.242 | 0.449 | 0.433 | 0.354 | 0.179 | 0.008 |
| Change In Working Capital
| -0.431 | -1.33 | -2.27 | -1.096 | 3.378 | 1.477 | 2.075 | 3.087 | 0.849 | -0.663 | 0.445 | -1.904 | 1.879 | -0.44 | 0.497 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| -0.174 | -0.548 | -0.243 | -2.107 | 1.651 | -0.414 | 1.423 | 0.681 | -0.171 | 0.441 | 1.546 | -0.946 | 0.711 | 0.273 | 0.379 |
| Other Working Capital
| -0.257 | -0.782 | -2.027 | 1.011 | 1.727 | 1.891 | 0.652 | 2.406 | 1.02 | -1.104 | -1.101 | -0.958 | 1.168 | -0.713 | 0.118 |
| Other Non Cash Items
| -0.731 | -0.89 | 1.537 | -1.306 | -0.64 | -0.44 | 0.019 | 0.337 | -0.225 | -0.054 | 0.019 | 0.023 | 0.019 | 0.011 | 0.379 |
| Operating Cash Flow
| -12.007 | -14.384 | -17.593 | -17.068 | -11.8 | -12.824 | -11.596 | -7.638 | -9.487 | -9.595 | -6.742 | -8.993 | -4.691 | -5.257 | -1.543 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -9.781 | -12.59 | 0 | -19.83 | -85.212 | -13.123 | -14.013 | -17.445 | -22.407 | -52.986 | -0.998 | -16.004 | -11.986 | -49.284 | 0 |
| Sales Maturities Of Investments
| 28.5 | 29.05 | 26.29 | 20.25 | 22.75 | 21 | 24.9 | 23.5 | 20.09 | 13.5 | 14.975 | 22.25 | 5 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 26.29 | 0 | -0.062 | 0.008 | 0.011 | 0.006 | -0.002 | -0.039 | 13.977 | 6.246 | -6.986 | -49.284 | 0 |
| Investing Cash Flow
| 18.719 | 16.46 | 26.29 | 0.42 | -62.462 | 7.877 | 10.887 | 6.055 | -2.317 | -39.486 | 13.977 | 6.246 | -6.986 | -49.284 | 0 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| -0.202 | 0 | 0.349 | -0.321 | 65.8 | 19.05 | 0.199 | 70.376 | -0.01 | 7.178 | 63.198 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.011 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.82 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.023 | 0 | 0.349 | 0 | 0.266 | 0 | 0.199 | 1.809 | 0 | 0 | 1.809 | -0.969 | -0.24 | 0 | 79.744 |
| Financing Cash Flow
| 0.023 | 0 | 0.349 | -0.321 | 66.066 | 19.05 | 0.199 | 70.365 | -0.01 | 7.178 | 63.187 | -0.969 | -0.24 | 0 | 79.744 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -70.365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 6.735 | 2.076 | 9.046 | -16.969 | -8.196 | 14.103 | -0.51 | -1.583 | -11.814 | -41.903 | 70.422 | -3.716 | -11.917 | -54.541 | 78.201 |
| Cash At End Of Period
| 33.504 | 26.769 | 24.693 | 15.647 | 32.616 | 40.812 | 26.709 | 27.219 | 28.802 | 40.616 | 82.519 | 12.097 | 15.813 | 27.73 | 82.271 |